Pavmed Inc (PAVM)

Jul 25, 2025

PAVmed Inc. Stock Analysis and ForecastExplosive capital appreciation - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about PAVmed Inc. stockFree Consultation - Autocar Professional

Jul 25, 2025

Jul 25, 2025

Will PAVmed Inc. stock split in the near futureFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

What drives PAVmed Inc. stock pricePhenomenal capital appreciation - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is PAVmed Inc. a good long term investmentFree Consultation - PrintWeekIndia

Jul 25, 2025

Jul 17, 2025

Why PAVmed Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - beatles.ru

Jul 17, 2025

Jul 17, 2025

Lucid says meeting scheduled to determine Medicare coverage for cancer test - MSN

Jul 17, 2025

Jul 16, 2025

Lucid says AdCom meeting set to determine cancer test coverage - Seeking Alpha

Jul 16, 2025

Jul 16, 2025

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test - StreetInsider

Jul 16, 2025

Jul 15, 2025

How PAVmed Inc. stock performs during market volatilityFree Low-Risk Investment Plans - Newser

Jul 15, 2025

Jul 15, 2025

What makes PAVmed Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser

Jul 15, 2025

Jun 24, 2025

PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equ - GuruFocus

Jun 24, 2025

Jun 23, 2025

PAVmed’s Veris Health Completes $2.5M Offering - TipRanks

Jun 23, 2025

Jun 18, 2025

PAVmed Holds Annual Stockholders Meeting, Approves Key Proposals - TipRanks

Jun 18, 2025

Jun 18, 2025

Leading California Hospital Network Launches Revolutionary 3-Minute Cancer Detection Test from Lucid Diagnostics - Stock Titan

Jun 18, 2025

Jun 18, 2025

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test - Finansavisen

Jun 18, 2025

Jun 07, 2025

PAVmed (NASDAQ:PAVM) Given New $19.00 Price Target at Ascendiant Capital Markets - Defense World

Jun 07, 2025

Jun 07, 2025

PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - MSN

Jun 07, 2025

Jun 06, 2025

PAVM: Ascendiant Capital Maintains Buy Rating but Lowers Price Target | PAVM Stock News - GuruFocus

Jun 06, 2025

Jun 04, 2025

PAVmed subsidiary Veris Health partners with Ohio State University cancer center - Yahoo Finance

Jun 04, 2025

Jun 03, 2025

Pavmed's Veris Health Signs Long-Term Partnership Deal With Ohio State University Hospital - marketscreener.com

Jun 03, 2025

Jun 03, 2025

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnersh - GuruFocus

Jun 03, 2025

Jun 03, 2025

PAVM Subsidiary Veris Health Partners with OSUCCC -- James for Cancer Care Innovations | PAVM Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with The Ohio State University Comprehensive Cancer CenterJames Cancer Hospital and Solove Research Institute | PAVM Sto - GuruFocus

Jun 03, 2025